| Abbreviation | Full Term |
| 8-OHdG | 8-hydroxy-2′-deoxyguanosine |
| AhR | Aryl hydrocarbon receptor |
| AOPPs | Advanced oxidation protein products |
| BP | Blood pressure |
| CAT | Catalase |
| CKD | Chronic kidney disease |
| CRP | C-reactive protein |
| CVD | Cardiovascular disease |
| eGFR | Estimated glomerular filtration rate |
| eNOS | Endothelial nitric oxide synthase |
| GLP-1RA | Glucagon-like peptide-1 receptor agonist |
| GPx | Glutathione peroxidase |
| GSH | Reduced glutathione |
| HPA axis | Hypothalamic–pituitary–adrenal axis |
| HDL | High-density lipoprotein |
| IL | Interleukin (IL-1β, IL-6, IL-10) |
| LDL | Low-density lipoprotein |
| MAPK | Mitogen-activated protein kinase |
| MDA | Malondialdehyde |
| MHY11 | Myosin heavy chain 11 |
| m6A | N6-methyladenosine (RNA modification) |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | NOD-like receptor family pyrin domain-containing 3 inflammasome |
| NOX | NADPH oxidase (isoforms: NOX4, NOX5) |
| Nrf2 | Nuclear factor erythroid 2–related factor 2 |
| OBS | Oxidative balance score |
| PCOS | Polycystic ovary syndrome |
| PNEI | Psycho-neuro-endocrine-immune axis |
| PPARs | Peroxisome proliferator-activated receptors |
| RAAS | Renin–angiotensin–aldosterone system |
| ROS | Reactive oxygen species |
| RUNX2 | Runt-related transcription factor 2 |
| SASP | Senescence-associated secretory phenotype |
| SGLT2(i) | Sodium–glucose cotransporter-2 (inhibitors) |
| SII | Systemic immune-inflammation index |
| SIRT1 | Sirtuin 1 |
| SOD | Superoxide dismutase |
| SREBP-1 | Sterol regulatory element-binding protein 1 |
| TBARS | Thiobarbituric acid reactive substances |
| TGF-β | Transforming growth factor beta |
| Th1/Th17 | T helper 1/T helper 17 cells |
| TLR(s) | Toll-like receptor(s) |
| TNF-α | Tumor necrosis factor alpha |